🤝 Excited to announce our partnership with LenioBio to accelerate de novo protein discovery.

By combining our Designerbodies™ with LenioBio’s ALiCE® cell-free system, we can go from design to test with unprecedented speed.

Full announcement: www.affinityai.dk/news-affinit...

👏 Big congrats to Max Overath, our CEO @tpjenkins.bsky.social, our CAIO Oliver Morell & collaborators on their new preprint on filtering de novo designed binders for in vitro success.

📄 www.biorxiv.org/content/10.1...